Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Amy E. Herr is Director at Bio-Techne. OQRO lists 16 transactions filed with the SEC under this name, the latest on Nov 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
16
Companies involved
1
As of the latest filing on , Amy E. Herr reported holding 6,006 shares of Bio-Techne (TECH), worth about $437K at the last close of $73 (Nov 18, 2026): 5,430 held directly and 576 through a significant other. In the last 12 months, Amy E. Herr sold $437K in 2 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bio-Techne TECH | 6,006 | 5,430 direct · 576 significant other | $73 | $437K | Oct 29, 2026 |
Is this Amy E. Herr’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Bio-TechneTECH
16 disclosures · Feb 2025 – Nov 2026 · 4 sold
Oct 29, 20262,750disclosed Nov 2
DetailsOfficial recordAug 17, 20261,381disclosed Aug 19
DetailsOfficial recordAug 15, 2026311disclosed Aug 18
DetailsOfficial recordAug 15, 2026589disclosed Aug 18
DetailsOfficial recordAug 15, 2026118disclosed Aug 18
DetailsOfficial recordAug 15, 2026160disclosed Aug 18
DetailsOfficial recordAug 15, 2026213disclosed Aug 18
DetailsOfficial recordMay 8, 2026Sold~$320Kdisclosed May 12
DetailsOfficial recordMay 8, 20266,636disclosed May 12
DetailsOfficial recordMay 8, 20266,636disclosed May 12
DetailsOfficial recordFeb 17, 2026Sold~$117Kdisclosed Feb 19
DetailsOfficial recordFeb 3, 202638disclosed Feb 5
DetailsOfficial recordFeb 3, 202638disclosed Feb 5
DetailsOfficial recordFeb 3, 202616disclosed Feb 5
DetailsOfficial recordJun 9, 2025Sold~$64Kdisclosed Jun 11
DetailsOfficial recordFeb 14, 2025Sold~$123Kdisclosed Feb 18
DetailsOfficial recordAmy E. Herr has no open-market purchase on record since 2025. Sales in 2 of the 2 years since 2025.
Amy E. Herr reported 0 open-market purchases and 4 sales since 2025; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $437K2×2 trades |
| 2025 | — | $186K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Amy E. Herr reported 0 open-market purchases and 4 sales here, 2025 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Oct 29, 2026, Amy E. Herr reported holding 6,006 shares of Bio-Techne (TECH), of which 576 are held indirectly. At the last close of $73 on Nov 18, 2026, that is about $437K. This is the stake disclosed in filings, not a net worth.
No public filing gives Amy E. Herr's net worth. What SEC Form 4 shows is the stock stake: 6,006 shares of Bio-Techne (TECH), about $437K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Amy E. Herr reported 2 open-market sales worth $437K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Amy E. Herr has no open-market purchase on record since 2025. Sales in 2 of the 2 years since 2025.
In SEC filings since 2025: no open-market purchase is on record; the latest open-market sale is from 2026.
Bio-Techne (TECH), from 2025 to 2026: 0 purchases and 4 sales.